Rephrase the title:Biotech Startup Wants Insulin More Affordable: How Can ‘Biosimilar’ Make a Difference? Health
Rephrase the title:Diabetes Relief: Major Manufacturers Cap Insulin Prices at $35, Answering Calls for Affordability in the US Health
